Esperion Therapeutics Annual Income Statement (NASDAQ:ESPR)

Add to My Stocks
$38.27 $0.67 (1.72%) ESPR stock closing price Mar 27, 2017 (Closing)
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011
Esperion Therapeutics Net Sales or Revenues
------
Cost Of Goods Sold (COGS)------
Esperion Therapeutics Gross Profit
------
Research & Development Expense57.86M29.8M25.3M16.01M7.99M7.8M
Selling General & Admin Expense18.28M20.23M10.92M6.74M2.2M2.35M
Income Before Depreciation Depletion Amortization-76.15M-50.04M-36.22M-22.75M-10.2M-10.16M
Depreciation Depletion Amortization------
Non Operating Income1.54M0.77M0.11M-2.39M0.03M-0.07M
Interest Expense0.37M0.52M0.27M0.93M1.48M0.57M
Esperion Therapeutics Pretax Income
-74.97M-49.78M-36.37M-26.08M-11.65M-10.81M
Provision for Income Taxes------
Minority Interest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-74.97M-49.78M-36.37M-26.08M-11.65M-10.81M
Extraordinary Items & Discontinued Operations------
Esperion Therapeutics Net Income (Profit/Loss)
-74.97M-49.78M-36.37M-26.08M-11.65M-10.81M
Average Shares used to compute Diluted EPS22.55M22.02M16.37M7.89M3.76M-
Average Shares used to compute Basic EPS22.55M22.02M16.37M7.89M3.76M-
Income Before Nonrecurring Items-74.98M-49.78M-36.38M-23.42M-11.74M-
Income from Nonrecurring Items----2.59M--
Esperion Therapeutics Earnings Per Share Basic Net
-3.33-2.26-2.22-3.31-3.13-
Esperion Therapeutics Earnings Per Share Diluted Net
-3.33-2.26-2.22-3.31-3.13-
EPS Diluted Before Nonrecurring Items-3.33-2.26-2.22-2.98-3.13-
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker